Symposium

Revisited Chemotherapy

    See also:
    A.I.-generated artist's impression of a cancer cell.

    Documents and media

    Program

    Introduction
    Hugues de Thé

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    New Approaches to Cancer Therapy
    Rene Bernards

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application
    Yves Pommier

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities
    Sophie Postel-Vinay

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Killing Cancer by DNA Damage Through Synthetic Lethality
    Thomas Helleday

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Metabolic Bases of Responses to Chemotherapy in Leukemia
    Jean-Emmanuel Sarry

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies
    Guillaume Bossis

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Microbially Derived Adjuvants for Cancer Chemotherapy
    Filipe Cabreiro

    -
    Not recorded
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Revisiting Chemotherapy Failure-From a Senescence Point-of-view
    Clemens Schmitt

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    Conclusions
    Hugues de Thé

    -
    Symposium
    Revisited Chemotherapy
    Salle 2, Site Marcelin Berthelot
    -

    See also

    Hugues de Thé, chair Cellular and Molecular Oncology